CSAC: The Largest Cannabis IPO with a SPAC Discount
February 7th, 2019
Exclusive, News, Top Story
Cannabis Strategies Acquisition Corp. (NEO: CSA) is poised to become one of the largest cannabis companies in the world. After raising C$135 million from investors, the special purpose acquisition company (SPAC) executed agreements to acquire five cannabis companies for its anchor portfolio. These geographically-diverse companies are projected to collectively generate C$260 in revenue and C$140 in adjusted EBITDA this year.
The company trades with a C$390 million equity market capitalization (based on 26m shares expected once the acquisitions close, which excludes impact from any warrants issued by CSA), which translates to a 3.5X 2019 adjusted EBITDA multiple—a significant discount to the more than 20X EBITDA multiple assigned to many industry peers. The valuation discount could close when it becomes a publicly-traded company, as more investors have an opportunity to buy the stock and tangible revenues appear in its SEDAR filings.
Cannabis Strategies Acquisition will become one of the largest cannabis companies in the world with an estimated C$260 million in revenue and C$140 million in adjusted EBTIDA this year across its portfolio. With over 325 employees, three cultivation facilities, and eight dispensaries, the company’s management team expects to produce over 31,000 kilograms of finished flower and 3,100,000 grams annually by next year.
|Selected 2018 – 2019 Targeted Consolidated Financials (in millions, C$)|
|Target Revenue||Target Adjusted EBITDA|
|Washoe||10 – 15||30 – 40||5 – 6||15 – 20|
|LivFree||40 – 45||50 – 60||10 – 13||20 – 30|
|Canopy||15 – 20||20 – 25||5 – 6||6 – 10|
|Sira||15 – 20||100 – 120||4 – 5||60 – 70|
|CannaPunch||7 – 10||20 – 25||4 – 5||10 – 15|
|Pro Forma Target Portfolio Combined||95 – 105||240 – 260||30 – 35||130 – 140|
In addition to the operational footprint, these acquisitions have created an exceptional management team led by CEO Jon Sandelman, Vice Chairman Mark Smith and COO Jennifer Drake. The team combines strong financial, strategy and management experience with proven world-class cannabis operations in the anchor portfolio, including successful up-and-running dispensaries and cultivation facilities, a line of premier edible brands, and leading manufacturing capabilities across the Western United States and in Massachusetts.
The company plans to expand into new markets and build its footprint in existing markets with limited licenses, while adding innovative new products to its brand portfolio. In particular, the management team is focused on companies that add material EBITDA within 12 months, especially when enhanced access to capital is required to meet that potential. Many portfolio companies have also accepted equity consideration in a vote of confidence.
Cannabis Strategies Acquisition plans to de-SPAC and become a publicly-traded company during the first quarter of this year. When this happens, the company could see a significant improvement in its valuation relative to its peers since the acquisitions will be finalized and more investors will be able to purchase its stock. Investors in the meantime have an opportunity to acquire the stock ahead of the de-SPAC on the NEO exchange.
At the same time, the company could rapidly scale up its presence by acquiring companies clustered in states around its anchor portfolio in the Eastern and Western United States. These acquisitions could further accelerate revenue and EBITDA growth moving forward and help create one of the largest cannabis companies in the world—and importantly, one of the only large cannabis brands located in the United States market.
Many institutional investors and public companies interested in exposure to the cannabis industry could also be interested in a large player in the space. For example, Canopy Growth Corp. (NYSE: CGC) (TSX: WEED) became the preferred partner for Constellation Brands Inc. (NYSE: STZ) when it was looking for exposure to cannabis. The U.S. market has been a little more challenging due to federal laws, but larger firms could have a long-term advantage.
Cannabis Strategies Acquisition Corp. (NEO: CSA) represents a unique opportunity to capitalize on growing demand for cannabis investments in the U.S. With plans to de-SPAC during the first quarter, investors could see a significant convergence in its valuation relative to other cannabis companies in the space. Investors may want to take a look at the restricted stock on the NEO exchange ahead of the de-SPAC for these reasons.
For more information, download their prospectus filings and investor presentations from SEDAR.
The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
Follow Us on Social Media
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.